Find Nadifloxacin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 124858-35-1, Jinofloxacin, Acuatim, Opc-7251, Nadixa, Opc 7251
Molecular Formula
C19H21FN2O4
Molecular Weight
360.4  g/mol
InChI Key
JYJTVFIEFKZWCJ-UHFFFAOYSA-N
FDA UNII
6CL9Y5YZEQ

Nadifloxacin
Nadifloxacin has been used in trials studying the treatment of Acne Vulgaris.
1 2D Structure

Nadifloxacin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid
2.1.2 InChI
InChI=1S/C19H21FN2O4/c1-10-2-3-12-16-13(18(24)14(19(25)26)9-22(10)16)8-15(20)17(12)21-6-4-11(23)5-7-21/h8-11,23H,2-7H2,1H3,(H,25,26)
2.1.3 InChI Key
JYJTVFIEFKZWCJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2N4CCC(CC4)O)F)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
6CL9Y5YZEQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2-carboxylic Acid

2. Opc 7251

3. Opc-7251

4. R-ndfx

5. S-ndfx

2.3.2 Depositor-Supplied Synonyms

1. 124858-35-1

2. Jinofloxacin

3. Acuatim

4. Opc-7251

5. Nadixa

6. Opc 7251

7. Nadifloxacine

8. Ndfx

9. Chebi:31889

10. Opc7251

11. 6cl9y5yzeq

12. Nsc-759622

13. S-nadifloxacin

14. 9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic Acid

15. Ncgc00164620-01

16. Nadifloxacino

17. Nadifloxacinum

18. Dsstox_cid_26483

19. Dsstox_rid_81654

20. Dsstox_gsid_46483

21. 1h,5h-benzo(ij)quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-

22. 9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic Acid

23. Nadifloxacine [inn-french]

24. Nadifloxacinum [inn-latin]

25. Nadifloxacino [inn-spanish]

26. 7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.0^{5,13}]trideca-2,5(13),6,8-tetraene-3-carboxylic Acid

27. Ccris 4066

28. Cas-124858-35-1

29. Sr-05000001516

30. Unii-6cl9y5yzeq

31. Nadoxin

32. Nadifloxacin [inn:ban:jan]

33. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-

34. Acuatim (tn)

35. Nadifloxacin (jan/inn)

36. Nadifloxacin [mi]

37. Nadifloxacin [inn]

38. Nadifloxacin [jan]

39. Schembl36593

40. Nadifloxacin [mart.]

41. 1h,5h-benzo(ij)quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (+-)-

42. Mls002154166

43. Nadifloxacin [who-dd]

44. Chembl363449

45. Dtxsid5046483

46. Hms2090d11

47. Hms2098o22

48. Hms2233d22

49. Hms3373h17

50. Hms3651j22

51. Hms3715o22

52. Pharmakon1600-01502312

53. Bcp05205

54. Hy-b0506

55. Tox21_112239

56. Bdbm50475222

57. Mfcd00865081

58. Nsc759622

59. S3105

60. Akos015895271

61. Tox21_112239_1

62. Ac-4283

63. Bcp9000975

64. Ccg-213817

65. Db12447

66. Ks-1210

67. Nsc 759622

68. Sb17161

69. Ncgc00164620-02

70. (+-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic Acid

71. 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid

72. Smr001233465

73. Db-041783

74. Ft-0631118

75. N0931

76. Sw199586-2

77. D01147

78. Ab00918517-07

79. Ab00918517_08

80. Ab00918517_09

81. 858n351

82. Q426605

83. J-005176

84. Sr-05000001516-1

85. Sr-05000001516-3

86. (+/-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic Acid

87. 1h,5h-benzo(ij)quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (+/-)-

88. 7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid

89. 8-(4-hydroxy-1-piperidyl)-9-fluoro-5-methyl-6,7-dihydro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid

90. 8-fluoro-5,6-dihydro-7-(4-hydroxypiperidino)-4-methyl-1-oxo-4h-3a-aza-1h-phenalene-2-carboxylic Acid

91. 81962-84-7

92. 9-fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid

93. 9-fluoro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic Acid

94. 9-fluoro-8-(4-hydroxy-1-piperidyl)-5-methyl-6,7-dihydro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid

95. 9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylicacid

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 360.4 g/mol
Molecular Formula C19H21FN2O4
XLogP32.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count2
Exact Mass360.14853532 g/mol
Monoisotopic Mass360.14853532 g/mol
Topological Polar Surface Area81.1 Ų
Heavy Atom Count26
Formal Charge0
Complexity631
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Topoisomerase II Inhibitors

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)


4.2 ATC Code

D - Dermatologicals

D10 - Anti-acne preparations

D10A - Anti-acne preparations for topical use

D10AF - Antiinfectives for treatment of acne

D10AF05 - Nadifloxacin


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q1","strtotime":1617129000,"product":"NADIFLOXACIN","address":"D-4, MIDC, CHIKALTHANA, Contact No: 919619382911","city":"AURANGABAD","supplier":"WOCKHARDT","supplierCountry":"INDIA","foreign_port":"BEIRUT","customer":"MEDIPHAR LABORATORIES","customerCountry":"LEBANON","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"3000","totalValueFC":"1428.5","currency":"USD","unitRateINR":208000,"date":"31-Mar-2021","totalValueINR":"104000","totalValueInUsd":"1428.5","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"9794618","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"LEBANON","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"D-4, MIDC, CHIKALTHANA, Contact No: 919619382911, AURANGABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1636482600,"product":"NADIFLOXACIN IH","address":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"EVA PHARMA","customerCountry":"EGYPT","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"1300","totalValueFC":"7627.1","currency":"USD","unitRateINR":94666.666666666672,"date":"10-Nov-2021","totalValueINR":"568000","totalValueInUsd":"7627.1","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"5905409","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637519400,"product":"NADIFLOXACIN","address":"","city":"","supplier":"M\/S RANIMAA HEALTHCARE","supplierCountry":"INDIA","foreign_port":"BEIRUT","customer":"TO THE ORDER OF","customerCountry":"LEBANON","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"2700","totalValueFC":"15764.5","currency":"USD","unitRateINR":195666.66666666666,"date":"22-Nov-2021","totalValueINR":"1174000","totalValueInUsd":"15764.5","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"6184972","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"LEBANON","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638210600,"product":"BULK DRUGS: NADIFLOXACIN","address":"WOCKHARDT TOWERS, BANDRA KURLACOMPLEX, BANDRA (E) ,","city":"MUMBAI, MAHARASHTRA.","supplier":"WOCKHARDT","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"SUNGWOO CHEMICAL","customerCountry":"KOREA, REPUBLIC OF","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"3000","totalValueFC":"5774","currency":"USD","unitRateINR":215000,"date":"30-Nov-2021","totalValueINR":"430000","totalValueInUsd":"5774","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"6390647","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"WOCKHARDT TOWERS, BANDRA KURLACOMPLEX, BANDRA (E) ,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639420200,"product":"NADIFLOXACIN IH","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"EVA PHARMA","customerCountry":"EGYPT","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"1300","totalValueFC":"7623.4","currency":"USD","unitRateINR":95833.333333333328,"date":"14-Dec-2021","totalValueINR":"575000","totalValueInUsd":"7623.4","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"6731067","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640629800,"product":"NADIFLOXACIN IN-HOUSE","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"EVA PHARMA","customerCountry":"EGYPT","quantity":"7.00","actualQuantity":"7","unit":"KGS","unitRateFc":"1300","totalValueFC":"9042","currency":"USD","unitRateINR":97428.571428571435,"date":"28-Dec-2021","totalValueINR":"682000","totalValueInUsd":"9042","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"7072768","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677090600,"product":"NADIFLOXACIN(JP) BATCH NO-TENFXTF001","address":"SPARC TANDALJA","city":"VADODARA","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"TOKYO - NARITA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"JAPAN","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"1.7","totalValueFC":"169.5","currency":"USD","unitRateINR":140,"date":"23-Feb-2023","totalValueINR":"14000","totalValueInUsd":"169.5","indian_port":"DELHI AIR","hs_no":"29333990","bill_no":"8003824","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"SPARC TANDALJA, VADODARA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689532200,"product":"NADIFLOXACIN IN-HOUSE","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"TO THE ORDER OF","customerCountry":"EGYPT","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"1300","totalValueFC":"7701.7","currency":"USD","unitRateINR":105500.031,"date":"17-Jul-2023","totalValueINR":"633000.186","totalValueInUsd":"7701.7","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698345000,"product":"HARMLESS PHARMACEUTICAL BULK DRUGNADIFLOXACIN (DEV.) BATCH-TENFXTF003MFD.DT.20.08.2023 EXP.20.01.2024","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"TOKYO - NARITA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"JAPAN","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"1709","totalValueFC":"108.1","currency":"USD","unitRateINR":90000,"date":"27-Oct-2023","totalValueINR":"9000","totalValueInUsd":"108.1","indian_port":"Delhi Air","hs_no":"29333990","bill_no":"4913474","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726857000,"product":"NADIFLOXACIN IH","address":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"JAKARTA","customer":"PT.IMEDCO DJAJA","customerCountry":"INDONESIA","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"5200","totalValueFC":"1220.4","currency":"USD","unitRateINR":409092,"date":"21-Sep-2024","totalValueINR":"102273","totalValueInUsd":"1220.4","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"4223257","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"INDONESIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD","customerAddress":""}]
31-Mar-2021
21-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for 124858-35-1 / Nadifloxacin API manufacturers, exporters & distributors?

Nadifloxacin manufacturers, exporters & distributors 1

66

PharmaCompass offers a list of Nadifloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nadifloxacin manufacturer or Nadifloxacin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nadifloxacin manufacturer or Nadifloxacin supplier.

PharmaCompass also assists you with knowing the Nadifloxacin API Price utilized in the formulation of products. Nadifloxacin API Price is not always fixed or binding as the Nadifloxacin Price is obtained through a variety of data sources. The Nadifloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Nadifloxacin

Synonyms

124858-35-1, Jinofloxacin, Acuatim, Opc-7251, Nadixa, Opc 7251

Cas Number

124858-35-1

Unique Ingredient Identifier (UNII)

6CL9Y5YZEQ

About Nadifloxacin

Nadifloxacin has been used in trials studying the treatment of Acne Vulgaris.

Nadifloxacin Manufacturers

A Nadifloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nadifloxacin, including repackagers and relabelers. The FDA regulates Nadifloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nadifloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Nadifloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Nadifloxacin Suppliers

A Nadifloxacin supplier is an individual or a company that provides Nadifloxacin active pharmaceutical ingredient (API) or Nadifloxacin finished formulations upon request. The Nadifloxacin suppliers may include Nadifloxacin API manufacturers, exporters, distributors and traders.

click here to find a list of Nadifloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Nadifloxacin USDMF

A Nadifloxacin DMF (Drug Master File) is a document detailing the whole manufacturing process of Nadifloxacin active pharmaceutical ingredient (API) in detail. Different forms of Nadifloxacin DMFs exist exist since differing nations have different regulations, such as Nadifloxacin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Nadifloxacin DMF submitted to regulatory agencies in the US is known as a USDMF. Nadifloxacin USDMF includes data on Nadifloxacin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nadifloxacin USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Nadifloxacin suppliers with USDMF on PharmaCompass.

Nadifloxacin JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Nadifloxacin Drug Master File in Japan (Nadifloxacin JDMF) empowers Nadifloxacin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Nadifloxacin JDMF during the approval evaluation for pharmaceutical products. At the time of Nadifloxacin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Nadifloxacin suppliers with JDMF on PharmaCompass.

Nadifloxacin KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Nadifloxacin Drug Master File in Korea (Nadifloxacin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nadifloxacin. The MFDS reviews the Nadifloxacin KDMF as part of the drug registration process and uses the information provided in the Nadifloxacin KDMF to evaluate the safety and efficacy of the drug.

After submitting a Nadifloxacin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nadifloxacin API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Nadifloxacin suppliers with KDMF on PharmaCompass.

Nadifloxacin GMP

Nadifloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Nadifloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nadifloxacin GMP manufacturer or Nadifloxacin GMP API supplier for your needs.

Nadifloxacin CoA

A Nadifloxacin CoA (Certificate of Analysis) is a formal document that attests to Nadifloxacin's compliance with Nadifloxacin specifications and serves as a tool for batch-level quality control.

Nadifloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Nadifloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Nadifloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Nadifloxacin EP), Nadifloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nadifloxacin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty